Distribution of HBV genotypes in Latin America

Imagem de Miniatura
Arquivos
art_ALVARADO-MORA_Distribution_of_HBV_genotypes_in_Latin_America_2013.PDF (652.26 KB)
Citações na Scopus
53
Tipo de produção
article
Data de publicação
2013
Editora
INT MEDICAL PRESS LTD
DOI
Indexadores
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Autores
ALVARADO-MORA, Monica V.
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
ANTIVIRAL THERAPY, v.18, n.3, p.459-465, 2013
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Approximately 2 billion people worldwide are infected with HBV, and 350 million people are chronic carriers. HBV is classified into nine genotypes (A to I). Genotype F is the most prevalent in the Spanish-speaking countries and in the Amerindian population in South America. HBV genotype F was primarily found in indigenous populations from South America and is divided into four subgenotypes (F1 to F4). Subgenotype F1 is further divided into F1a (found in Costa Rica and El Salvador) and F1b (found in in Alaska, Argentina and Chile). Subgenotypes F2 and F3 cocirculate in the north of South America: F2a is found in Brazil and Venezuela, F2b is described only in Venezuela, F3 is frequent in Colombia, Venezuela and Panama, and F4 is reported from the central and south areas of South America, including Bolivia, Argentina and southern Brazil. HBV genotypes and subgenotypes have distinct geographical distributions. It is currently under discussion whether they are associated with different prognoses, considering the patterns of severity of liver diseases in various populations. Furthermore, global human migrations affect the pattern of genotype distribution, introducing genotypes differing from those found in the original inhabitants.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/7861
Referências
  1. Alvarado Mora MV, 2011, VIROLOGY J S1, V54, p886A
  2. Alvarado-Mora MV, 2011, MEM I OSWALDO CRUZ, V106, P495, DOI 10.1590/S0074-02762011000400017
  3. Alvarado Mora Mónica Viviana, 2011, Infect Genet Evol, V11, P103, DOI 10.1016/j.meegid.2010.10.003
  4. Alvarado-Mora MV, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-415
  5. Andernach IE, 2009, EMERG INFECT DIS, V15, P1222, DOI 10.3201/eid1508.081642
  6. ArauzRuiz P, 1997, J MED VIROL, V51, P305, DOI 10.1002/(SICI)1096-9071(199704)51:4<305::AID-JMV8>3.0.CO;2-9
  7. Arauz-Ruiz P, 2002, J GEN VIROL, V83, P2059
  8. Bertolini DA, 2012, INFECT GENET EVOL, V12, P1295, DOI 10.1016/j.meegid.2012.04.009
  9. Bottecchia M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-11
  10. Bouckaert R, 2013, ANTIVIR THER, V18, P497, DOI 10.3851/IMP2656
  11. Bowyer SM, 1997, J GEN VIROL, V78, P1719
  12. Cardona NE, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-527
  13. Castilho MD, 2012, AM J TROP MED HYG, V87, P768, DOI 10.4269/ajtmh.2012.12-0083
  14. Chandra PK, 2009, J VIRAL HEPATITIS, V16, P749, DOI 10.1111/j.1365-2893.2009.01129.x
  15. Delfino CM, 2012, J CLIN VIROL, V54, P174, DOI 10.1016/j.jcv.2012.02.023
  16. Devesa M, 2007, VIRUS RES, V127, P177, DOI 10.1016/j.virusres.2007.01.004
  17. Devesa M, 2008, J MED VIROL, V80, P20, DOI 10.1002/jmv.21024
  18. Di Lello FA, 2009, J MED VIROL, V81, P1887, DOI 10.1002/jmv.21607
  19. Garcia-Montalvo BM, 2011, ANN HEPATOL, V10, P133
  20. Godoy BA, 2013, ANTIVIR THER, V18, P505, DOI 10.3851/IMP2600
  21. Hannoun C, 2005, J GEN VIROL, V86, P2163, DOI 10.1099/vir.0.80972-0
  22. Holmes EC, 2008, ANNU REV MICROBIOL, V62, P307, DOI 10.1146/annurev.micro.62.081307.162912
  23. Hubschen JM, 2011, CLIN MICROBIOL INFEC, V17, P88, DOI 10.1111/j.1469-0691.2010.03205.x
  24. Huy TTT, 2006, ARCH VIROL, V151, P589, DOI 10.1007/s00705-005-0671-1
  25. Jardi R, 2008, J HEPATOL, V49, P695, DOI 10.1016/j.jhep.2008.03.030
  26. Khan A, 2008, VIRUS RES, V132, P174, DOI 10.1016/j.virusres.2007.12.005
  27. Kramvis A, 2008, J MED VIROL, V80, P27, DOI 10.1002/jmv.21049
  28. Kramvis A, 2007, HEPATOL RES, V37, pS27, DOI 10.1111/j.1872-034X.2007.00100.x
  29. Kurbanov F, 2005, J GEN VIROL, V86, P2047, DOI 10.1099/vir.0.80922-0
  30. Leone FGPY, 2008, J CLIN VIROL, V42, P381, DOI 10.1016/j.jcv.2008.01.018
  31. Machado IV, 1988, VIRAL HEPATITIS LIVE, P174
  32. Machado IV, 2010, ANN HEPATOL, V9, P172
  33. Magnius LO, 1995, INTERVIROLOGY, V38, P24
  34. Mahtab MA, 2008, HEPATOB PANCREAT DIS, V7, P457
  35. Marin JAM, 2012, ANN HEPATOL, V11, P47
  36. Meldal BHM, 2009, J GEN VIROL, V90, P1622, DOI 10.1099/vir.0.009738-0
  37. Mello FCA, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-103
  38. Mora MVA, 2010, J GEN VIROL, V91, P501, DOI 10.1099/vir.0.015958-0
  39. Moraes MTB, 1999, BRAZ J MED BIOL RES, V32, P45, DOI 10.1590/S0100-879X1999000100006
  40. Motta-Castro A, 2008, ARCH VIROL, V153, P2197, DOI 10.1007/s00705-008-0237-0
  41. Motta-Castro ARC, 2005, J MED VIROL, V77, P188, DOI 10.1002/jmv.20435
  42. Mulyanto, 2011, J MED VIROL, V83, P54, DOI 10.1002/jmv.21931
  43. Mutimer D, 2001, J CLIN VIROL, V21, P239, DOI 10.1016/S1386-6532(00)00166-9
  44. Norder H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872
  45. OKAMOTO H, 1988, J GEN VIROL, V69, P2575, DOI 10.1099/0022-1317-69-10-2575
  46. Olinger CM, 2006, J GEN VIROL, V87, P1163, DOI 10.1099/vir.0.81614-0
  47. Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116
  48. Panduro A, 2013, ANTIVIR THER, V18, P475, DOI 10.3851/IMP2605
  49. Pezzano SC, 2011, CLIN MICROBIOL INFEC, V17, P223, DOI 10.1111/j.1469-0691.2010.03283.x
  50. Pourkarim MR, 2010, J CLIN VIROL, V47, P93, DOI 10.1016/j.jcv.2009.09.032
  51. Pourkarim MR, 2010, J CLIN VIROL, V47, P356, DOI 10.1016/j.jcv.2010.01.015
  52. Quintero A, 2002, ARCH VIROL, V147, P1829, DOI 10.1007/s00705-002-0842-2
  53. Roman S, 2010, J MED VIROL, V82, P1527, DOI 10.1002/jmv.21846
  54. Sakamoto T, 2006, J GEN VIROL, V87, P1873, DOI 10.1099/vir.0.81714-0
  55. Sanchez LV, 2007, INTERVIROLOGY, V50, P9, DOI 10.1159/000096307
  56. Santos AO, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-315
  57. Schaefer S, 2007, WORLD J GASTROENTERO, V13, P14
  58. Shen T, 2009, INTERVIROLOGY, V52, P340, DOI 10.1159/000252912
  59. Silva Adriana Cristina da, 2010, Mem Inst Oswaldo Cruz, V105, P770, DOI 10.1590/S0074-02762010000600007
  60. Simmonds P, 2005, J VIROL, V79, P15467, DOI 10.1128/JVI.79.24.15467-15476.2005
  61. Sitnik R, 2007, BRAZ J MED BIOL RES, V40, P1689, DOI 10.1590/S0100-879X2006005000185
  62. Sitnik R, 2004, J CLIN MICROBIOL, V42, P2455, DOI 10.1128/JCM.42.6.2455-2460.2004
  63. Sugauchi F, 2004, CLIN INFECT DIS, V38, P1222, DOI 10.1086/382885
  64. Tatematsu K, 2009, J VIROL, V83, P10538, DOI 10.1128/JVI.00462-09
  65. Te Helen S, 2010, Clin Liver Dis, V14, P1, DOI 10.1016/j.cld.2009.11.009
  66. Torres C, 2011, MOL PHYLOGENET EVOL, V59, P114, DOI 10.1016/j.ympev.2011.01.010
  67. Utama A, 2009, WORLD J GASTROENTERO, V15, P4028, DOI 10.3748/wjg.15.4028
  68. Venegas M, 2011, J MED VIROL, V83, P1530, DOI 10.1002/jmv.22129
  69. Venegas M, 2008, ARCH VIROL, V153, P2129, DOI 10.1007/s00705-008-0231-6
  70. von Meltzer M, 2008, VIRUS GENES, V37, P225, DOI 10.1007/s11262-008-0261-x
  71. Yu H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009297

Coleções
Artigos e Materiais de Revistas Científicas - LIM/07
Artigos e Materiais de Revistas Científicas - HC/ICHC